Phe K - Search Results

1

Significant Publications on Infectious Diseases Pharmacotherapy in 2016.

Fong G, Skoglund EW, Phe K, Guastadisegni J, Shea KM, McDaneld PM, Perez KK, Sofjan AK. Fong G, et al. Among authors: phe k. J Pharm Pract. 2018 Oct;31(5):469-480. doi: 10.1177/0897190017727212. Epub 2017 Aug 29. J Pharm Pract. 2018. PMID: 28847232 Review.

2

Significant Publications on Infectious Diseases Pharmacotherapy in 2017.

Skoglund EW, Dotson KM, Dempsey CJ, Su CP, Foolad F, Janak C, Sofjan AK, Phe K. Skoglund EW, et al. Among authors: phe k. J Pharm Pract. 2019 Oct;32(5):534-545. doi: 10.1177/0897190018792797. Epub 2018 Aug 13. J Pharm Pract. 2019. PMID: 30099951 Review.

3

Significant Publications on Infectious Diseases Pharmacotherapy in 2018.

Borjan J, Gonzales-Luna AJ, Carlson TJ, Finch NA, Mitchell AP, McDaneld PM, Phe K, Foolad F. Borjan J, et al. Among authors: phe k. J Pharm Pract. 2019 Oct;32(5):546-557. doi: 10.1177/0897190019863921. Epub 2019 Jul 21. J Pharm Pract. 2019. PMID: 31327285 Review.

4

Significant publications on infectious diseases pharmacotherapy in 2014.

Phe K, Cadle RM, Guervil DJ, Guzman OE, Lockwood AM, Perez KK, Vuong NN, Aitken SL; Houston Infectious Diseases Network. Phe K, et al. Am J Health Syst Pharm. 2015 Aug 15;72(16):1380-92. doi: 10.2146/ajhp150112. Am J Health Syst Pharm. 2015. PMID: 26246295

5

In vitro assessment and multicenter cohort study of comparative nephrotoxicity rates associated with colistimethate versus polymyxin B therapy.

Phe K, Lee Y, McDaneld PM, Prasad N, Yin T, Figueroa DA, Musick WL, Cottreau JM, Hu M, Tam VH. Phe K, et al. Antimicrob Agents Chemother. 2014 May;58(5):2740-6. doi: 10.1128/AAC.02476-13. Epub 2014 Feb 24. Antimicrob Agents Chemother. 2014. PMID: 24566187 Free PMC article.

6

An institutional review of antimicrobial stewardship interventions.

Cao H, Phe K, Laine GA, Russo HR, Putney KS, Tam VH. Cao H, et al. Among authors: phe k. J Glob Antimicrob Resist. 2016 Sep;6:75-77. doi: 10.1016/j.jgar.2016.03.006. Epub 2016 May 4. J Glob Antimicrob Resist. 2016. PMID: 27530844

7

Optimizing Pharmacokinetics-Pharmacodynamics of Antimicrobial Management in Patients with Sepsis: A Review.

Phe K, Heil EL, Tam VH. Phe K, et al. J Infect Dis. 2020 Jul 21;222(Suppl 2):S132-S141. doi: 10.1093/infdis/jiaa118. J Infect Dis. 2020. PMID: 32691832 Free PMC article. Review.

8

Using clinical decision support to improve urine culture diagnostic stewardship, antimicrobial stewardship, and financial cost: A multicenter experience.

Watson KJ, Trautner B, Russo H, Phe K, Lasco T, Pipkins T, Lembcke B, Al Mohajer M. Watson KJ, et al. Among authors: phe k. Infect Control Hosp Epidemiol. 2020 May;41(5):564-570. doi: 10.1017/ice.2020.37. Epub 2020 Mar 5. Infect Control Hosp Epidemiol. 2020. PMID: 32131910

9

An integrated approach to evaluate different tetracycline derivatives for formulary decisions.

Zidaru A, Phe K, Lasco TM, Tam VH. Zidaru A, et al. Among authors: phe k. Am J Health Syst Pharm. 2022 Mar 7;79(6):467-471. doi: 10.1093/ajhp/zxab451. Am J Health Syst Pharm. 2022. PMID: 34849535

10

Outcomes of empiric aminoglycoside monotherapy for Pseudomonas aeruginosa bacteremia.

Phe K, Bowers DR, Babic JT, Tam VH. Phe K, et al. Diagn Microbiol Infect Dis. 2019 Apr;93(4):346-348. doi: 10.1016/j.diagmicrobio.2018.10.019. Epub 2018 Nov 9. Diagn Microbiol Infect Dis. 2019. PMID: 30522794

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

18 results

Search Page